Cargando…
Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
Doxorubicin is the chemotherapeutic drug of choice for a wide variety of cancers, and cardiotoxicity is one of the major side effects of doxorubicin treatment. One of the main cellular targets of doxorubicin in the heart is mitochondria. Mitochondrial sirtuin, SIRT3 has been shown to protect against...
Autores principales: | Pillai, Vinodkumar B., Kanwal, Abhinav, Fang, Yong Hu, Sharp, Willard W., Samant, Sadhana, Arbiser, Jack, Gupta, Mahesh P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470953/ https://www.ncbi.nlm.nih.gov/pubmed/28423723 http://dx.doi.org/10.18632/oncotarget.16133 |
Ejemplares similares
-
Honokiol blocks and reverses cardiac hypertrophy in mice by
activating mitochondrial SIRT3
por: Pillai, Vinodkumar B., et al.
Publicado: (2015) -
Skeletal muscle‐specific over‐expression of the nuclear sirtuin SIRT6 blocks cancer‐associated cachexia by regulating multiple targets
por: Samant, Sadhana A., et al.
Publicado: (2020) -
The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
por: Samant, Sadhana A., et al.
Publicado: (2017) -
The nuclear sirtuin SIRT6 protects the heart from developing aging-associated myocyte senescence and cardiac hypertrophy
por: Pillai, Vinodkumar B., et al.
Publicado: (2021) -
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
por: Akamata, Kaname, et al.
Publicado: (2016)